IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
Compound with spectra: 1 NMR
![IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE](/api/compound/5ZR1jty9inv.png?ph=true&h=300&w=458 "IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE")
| SpectraBase Compound ID | 5ZR1jty9inv |
|---|---|
| InChI | InChI=1S/C24H27N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h4,6-9,11-14,16,22H,1,5,10,15H2,2-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
| InChIKey | JGXVCPPNGBWLGQ-QFIPXVFZSA-N |
| Mol Weight | 433.51 g/mol |
| Molecular Formula | C24H27N5O3 |
| Exact Mass | 433.21139 g/mol |
| Enantiomer InChIKey | JGXVCPPNGBWLGQ-JOCHJYFZSA-N |
| Racemate InChIKey | JGXVCPPNGBWLGQ-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
Valsartane
Valsartan
IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
2-(4'-TRIFLUOROMETHYL-BIPHENYL-2-YL)-4(5)-(4-METHOXYPHENYL)-IMIDAZOLE
(S)-N,N'-BIS-(4-METHOXYBENZYL)-3-ISOPROPYLPIPERAZINE-2,5-DIONE
(2R,3S)-1-Benzyl-3-phenylpyroglutamic acid
Ethyl 2'-(3-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxylate
Ethyl 2'-(3-methylpyrazin-2-yl)-[1,1'-biphenyl]-4-carboxylate
2-Methyl-3-(4'-nitro-[1,1'-biphenyl]-2-yl)pyrazine
2-{(2-Chloroacetyl)-[1-(4-trifluoromethylphenyl)ethyl]amino}-3-phenylpropionic acid methyl ester isomer
| Title | Journal or Book | Year |
|---|---|---|
| Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist | Journal of Pharmaceutical and Biomedical Analysis | 2009 |